Related Experiment Video
Updated: Jul 18, 2026
11:38
High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Published on: May 10, 2016
On the long-term toxic risk of dinaline
1Institute of Toxicology and Chemotherapy, German Cancer Research Center, Heidelberg.
Cancer Letters
|December 1, 1991
Summary
The cytostatic agent dinaline demonstrated long-term toxic risk modulation in rats, increasing survival in females and reducing malignant tumors in males. Benign tumors increased in males, suggesting a potential hormone-related mechanism.
Area of Science:
- Oncology
- Toxicology
- Carcinogenesis Research
Background:
- Cytostatic agents are used in cancer therapy but can pose long-term toxic risks.
- Understanding the carcinogenic potential and long-term effects of cytostatic agents is crucial for patient safety.
- Dinaline (4-amino-N-(2'-aminophenyl)-benzamide) is a cytostatic agent whose long-term toxicological profile requires thorough investigation.
Purpose of the Study:
- To assess the long-term toxicological risk and carcinogenic potential of the cytostatic agent dinaline in a rat bioassay.
- To evaluate the effect of dinaline on survival rates, tumor incidence, and tumor manifestation time in rats.
- To investigate the organ-specific distribution of neoplastic lesions induced by dinaline.
Main Methods:
- A 106-week rat bioassay was conducted with regular administration of dinaline at doses of 9, 3, and 1 mg/kg.
- Survival rates, tumor types (malignant and benign), and time to tumor manifestation were recorded.
- Organ-specific tumor incidence was analyzed to determine dose-dependent effects.
Main Results:
- Dinaline administration at median and low doses significantly increased survival in female rats.
- A significant reduction in malignant tumors was observed in male rats, with prolonged manifestation time for malignancies in females.
- Benign neoplasms increased in male rats, while incidences in female rats did not differ significantly from controls. Organ-specific analysis revealed decreased tumor incidence in hematopoietic, lymphatic, mammary, and pituitary tissues, and increased incidence in adrenal glands, gonads, and vagina.
Conclusions:
- Dinaline acts as a modulator of carcinogenesis in rats, exhibiting differential effects on malignant and benign tumor development.
- The observed pattern of decreased and increased tumor incidences suggests a hormone-related mechanism of action for dinaline.
- Further research into the hormonal interactions of dinaline is warranted to fully elucidate its toxicological profile and therapeutic potential.
Related Concept Videos
01:26Physical Properties of Amines
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
01:26Toxic Reactions: Overview
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:30Toxidromes: Clinical Features
Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...